Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy

John Nemunaitis; Laura Stanbery; Adam Walter; Gladice Wallraven; Alexander Nemunaitis; Staci Horvath; Ernest Bognar; Donald Rao; Steven Engle; Scott Brun; Maurizio Ghisoli; Rodney P Rocconi; Bradley J Monk; Robert L Coleman

doi:10.1080/14796694.2024.2376518

Back

Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy

Journal article

Open access

Peer reviewed

Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy

John Nemunaitis, Laura Stanbery, Adam Walter, Gladice Wallraven, Alexander Nemunaitis, Staci Horvath, Ernest Bognar, Donald Rao, Steven Engle, Scott Brun, …

Future oncology (London, England), pp.1-16

08/05/2024

DOI: https://doi.org/10.1080/14796694.2024.2376518

Files and links (1)

url

https://doi.org/10.1080/14796694.2024.2376518View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy
Creators: John Nemunaitis - Gradalis
Laura Stanbery - Gradalis
Adam Walter - Gradalis
Gladice Wallraven - Gradalis
Alexander Nemunaitis - Gradalis
Staci Horvath - Gradalis
Ernest Bognar - Gradalis
Donald Rao - Gradalis
Steven Engle - Gradalis
Scott Brun - Product Innovation and Engineering (United States, Saint James) - LLC
Maurizio Ghisoli - Texas Oncology
Rodney P Rocconi - University of Mississippi Medical Center
Bradley J Monk - HonorHealth
Robert L Coleman - The US Oncology Network
Publication Details: Future oncology (London, England), pp.1-16
Identifiers: 991006108172002656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article